-+ 0.00%
-+ 0.00%
-+ 0.00%

Evommune Q3 EPS $(0.85) Misses $(0.84) Estimate

Benzinga·11/12/2026 21:42:05
Evommune (NYSE:EVMN) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.84) by 1.19 percent. This is a 89.47 percent increase over losses of $(8.07) per share from the same period last year.